Literature DB >> 7578538

Age and secular trends in risk factors for cardiovascular disease in Busselton.

M W Knuiman1, K Jamrozik, T A Welborn, M K Bulsara, M L Divitini, D E Whittall.   

Abstract

Mortality rates from heart disease and stroke in Australia have been falling for more than 20 years. No completely satisfactory explanations for this trend exist. However, it is believed to be due, at least in part, to changes in the incidence of cardiovascular disease arising from changes in the prevalence and severity of risk factors for cardiovascular disease. The adult community of Busselton in Western Australia participated in cross-sectional health surveys every three years from 1966 to 1981. This paper describes secular trends from 1966 to 1981 and age trends from 25 to 80 years for cardiovascular risk factors in Busselton men and women. Downwards secular trends were observed for mean blood pressure and smoking for men and women, upwards trends were observed for body mass index in men, and mean cholesterol was approximately constant over this period. The age and secular trends were consistent with other Australian studies conducted in the 1980s and with overseas studies. An estimated 67 per cent of the decline in cardiovascular mortality rates among Busselton men and 22 per cent of the decline among Busselton women may be attributed to changes in the prevalence of risk factors for cardiovascular disease.

Entities:  

Mesh:

Year:  1995        PMID: 7578538     DOI: 10.1111/j.1753-6405.1995.tb00389.x

Source DB:  PubMed          Journal:  Aust J Public Health        ISSN: 1035-7319


  15 in total

1.  Cohort profile: the Western Australian Sleep Health Study.

Authors:  Sutapa Mukherjee; David Hillman; Jessica Lee; Annette Fedson; Laila Simpson; Kim Ward; Gregory Love; Cass Edwards; Bernadett Szegner; Lyle John Palmer
Journal:  Sleep Breath       Date:  2011-02-12       Impact factor: 2.816

2.  Lower Circulating Androgens Are Associated with Overall Cancer Risk and Prostate Cancer Risk in Men Aged 25-84 Years from the Busselton Health Study.

Authors:  Yi X Chan; Matthew W Knuiman; Mark L Divitini; David J Handelsman; John P Beilby; Bu B Yeap
Journal:  Horm Cancer       Date:  2018-08-10       Impact factor: 3.869

3.  Decline in lung function and mortality: the Busselton Health Study.

Authors:  G Ryan; M W Knuiman; M L Divitini; A James; A W Musk; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  1999-04       Impact factor: 3.710

4.  Secular trends in blood pressure during early-to-middle adulthood: the Fels Longitudinal Study.

Authors:  Audrey C Choh; Ramzi W Nahhas; Miryoung Lee; Youn Su Choi; William C Chumlea; Dana L Duren; Richard J Sherwood; Bradford Towne; Roger M Siervogel; Ellen W Demerath; Stefan A Czerwinski
Journal:  J Hypertens       Date:  2011-05       Impact factor: 4.844

5.  Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores.

Authors:  M W Knuiman; H T Vu
Journal:  J Epidemiol Community Health       Date:  1997-10       Impact factor: 3.710

6.  Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

Authors:  L J Lambert; J A Y Straton; M W Knuiman; H C Bartholomew
Journal:  J Epidemiol Community Health       Date:  2003-04       Impact factor: 3.710

7.  Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia.

Authors:  Joseph Hung; John P Beilby; Matthew W Knuiman; Mark Divitini
Journal:  BMJ       Date:  2003-01-18

8.  The association of common genetic variants in the APOA5, LPL and GCK genes with longitudinal changes in metabolic and cardiovascular traits.

Authors:  R J Webster; N M Warrington; M N Weedon; A T Hattersley; P A McCaskie; J P Beilby; L J Palmer; T M Frayling
Journal:  Diabetologia       Date:  2008-11-19       Impact factor: 10.122

9.  The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.

Authors:  J Danesh; S Erqou; M Walker; S G Thompson; R Tipping; C Ford; S Pressel; G Walldius; I Jungner; A R Folsom; L E Chambless; M Knuiman; P H Whincup; S G Wannamethee; R W Morris; J Willeit; S Kiechl; P Santer; A Mayr; N Wald; S Ebrahim; D A Lawlor; J W G Yarnell; J Gallacher; E Casiglia; V Tikhonoff; P J Nietert; S E Sutherland; D L Bachman; J E Keil; M Cushman; B M Psaty; R P Tracy; A Tybjaerg-Hansen; B G Nordestgaard; R Frikke-Schmidt; S Giampaoli; L Palmieri; S Panico; D Vanuzzo; L Pilotto; L Simons; J McCallum; Y Friedlander; F G R Fowkes; A J Lee; F B Smith; J Taylor; J Guralnik; C Phillips; R Wallace; D Blazer; K T Khaw; J H Jansson; C Donfrancesco; V Salomaa; K Harald; P Jousilahti; E Vartiainen; M Woodward; R B D'Agostino; P A Wolf; R S Vasan; M J Pencina; E M Bladbjerg; T Jorgensen; L Moller; J Jespersen; R Dankner; A Chetrit; F Lubin; A Rosengren; L Wilhelmsen; G Lappas; H Eriksson; C Bjorkelund; P Cremer; D Nagel; R Tilvis; T Strandberg; B Rodriguez; L M Bouter; R J Heine; J M Dekker; G Nijpels; C D A Stehouwer; E Rimm; J Pai; S Sato; H Iso; A Kitamura; H Noda; U Goldbourt; V Salomaa; J T Salonen; K Nyyssönen; T-P Tuomainen; D Deeg; J L Poppelaars; T Meade; J Cooper; B Hedblad; G Berglund; G Engstrom; A Döring; W Koenig; C Meisinger; W Mraz; L Kuller; R Selmer; A Tverdal; W Nystad; R Gillum; M Mussolino; S Hankinson; J Manson; B De Stavola; C Knottenbelt; J A Cooper; K A Bauer; R D Rosenberg; S Sato; Y Naito; I Holme; H Nakagawa; H Miura; P Ducimetiere; X Jouven; C Crespo; M Garcia-Palmieri; P Amouyel; D Arveiler; A Evans; J Ferrieres; H Schulte; G Assmann; J Shepherd; C Packard; N Sattar; B Cantin; B Lamarche; J-P Després; G R Dagenais; E Barrett-Connor; D Wingard; R Bettencourt; V Gudnason; T Aspelund; G Sigurdsson; B Thorsson; M Trevisan; J Witteman; I Kardys; M Breteler; A Hofman; H Tunstall-Pedoe; R Tavendale; G D O Lowe; Y Ben-Shlomo; B V Howard; Y Zhang; L Best; J Umans; A Onat; T W Meade; I Njolstad; E Mathiesen; M L Lochen; T Wilsgaard; J M Gaziano; M Stampfer; P Ridker; H Ulmer; G Diem; H Concin; F Rodeghiero; A Tosetto; E Brunner; M Shipley; J Buring; S M Cobbe; I Ford; M Robertson; Y He; A M Ibanez; E J M Feskens; D Kromhout; R Collins; E Di Angelantonio; S Kaptoge; S Lewington; L Orfei; L Pennells; P Perry; K Ray; N Sarwar; M Scherman; A Thompson; S Watson; F Wensley; I R White; A M Wood
Journal:  Eur J Epidemiol       Date:  2007-09-18       Impact factor: 8.082

10.  A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome.

Authors:  Kirsten E Peters; John Beilby; Gemma Cadby; Nicole M Warrington; David G Bruce; Wendy A Davis; Timothy Me Davis; Steven Wiltshire; Matthew Knuiman; Brendan M McQuillan; Lyle J Palmer; Peter L Thompson; Joseph Hung
Journal:  BMC Med Genet       Date:  2013-01-25       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.